Johnson & Johnson’s single-dose vaccine has now been granted emergency use authorization, the third vaccine to be approved for emergency use in the nation during the COVID-19 pandemic.
Unlike the Pfizer and Moderna vaccines, Johnson & Johnson’s shot works with just one dose instead of two.
The FDA said the latest vaccine authorized strong protection against serious illness, hospitalizations, and death. One dose was 85% protective against the most severe COVID-19 infection.
Should you be concerned about Johnson & Johnson’s COVID vaccine being less effective?
Dr. Vin Gupta, a public health analyst, told NBC that although Johnson & Johnson’s COVID-19 vaccine is less effective than the vaccines from Pfizer and Moderna, Americans should “absolutely not” have any fear about receiving the single-dose shot. Gupta explained how this specific vaccine “checks all the boxes.”
“You get a vaccine to avert disease and to avoid the hospital, and that’s exactly what this does,” Gupta added.
Gupta also urges many that the Johnson & Johnson vaccine is no different from the Moderna and Pfizer vaccines.
The J&J vaccine is considered to be 72 percent effective in the U.S., according to a PBS story, while both Pfizer and Moderna boast about a 90 percent efficacy rate. The J&J vaccine is also easier to store.
According to the Centers for Disease Control and Prevention, more than 68 million vaccine doses have been administered in the United States. As of February 25, the number of doses distributed in the country stands at more than 91 million.
Earlier this week, the Johnson & Johnson vaccine met the requirements for vaccine approval to fight moderate to severe/critical cases of the virus.